666 related articles for article (PubMed ID: 33298911)
1. TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation.
Li K; Wang F; Yang ZN; Zhang TT; Yuan YF; Zhao CX; Yeerjiang Z; Cui B; Hua F; Lv XX; Zhang XW; Yu JJ; Liu SS; Yu JM; Shang S; Xiao Y; Hu ZW
Nat Commun; 2020 Dec; 11(1):6316. PubMed ID: 33298911
[TBL] [Abstract][Full Text] [Related]
2. TRIB3 Stabilizes High TWIST1 Expression to Promote Rapid APL Progression and ATRA Resistance.
Lin J; Zhang W; Niu LT; Zhu YM; Weng XQ; Sheng Y; Zhu J; Xu J
Clin Cancer Res; 2019 Oct; 25(20):6228-6242. PubMed ID: 31235507
[TBL] [Abstract][Full Text] [Related]
3. TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence.
Li K; Wang F; Cao WB; Lv XX; Hua F; Cui B; Yu JJ; Zhang XW; Shang S; Liu SS; Yu JM; Han MZ; Huang B; Zhang TT; Li X; Jiang JD; Hu ZW
Cancer Cell; 2017 May; 31(5):697-710.e7. PubMed ID: 28486108
[TBL] [Abstract][Full Text] [Related]
4. TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target.
Yu JJ; Zhou DD; Yang XX; Cui B; Tan FW; Wang J; Li K; Shang S; Zhang C; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Huang B; Hua F; Hu ZW
Nat Commun; 2020 Jul; 11(1):3660. PubMed ID: 32694521
[TBL] [Abstract][Full Text] [Related]
5. Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression.
Li K; Zhang TT; Wang F; Cui B; Zhao CX; Yu JJ; Lv XX; Zhang XW; Yang ZN; Huang B; Li X; Hua F; Hu ZW
Oncogene; 2018 May; 37(22):2967-2981. PubMed ID: 29520103
[TBL] [Abstract][Full Text] [Related]
6. TRIB3 destabilizes tumor suppressor PPARα expression through ubiquitin-mediated proteasome degradation in acute myeloid leukemia.
Luo X; Zhong L; Yu L; Xiong L; Dan W; Li J; Ye J; Chu X; Liu C; Liu B
Life Sci; 2020 Sep; 257():118021. PubMed ID: 32621919
[TBL] [Abstract][Full Text] [Related]
7. TRIB3-TRIM8 complex drives NAFLD progression by regulating HNF4α stability.
Xiao MC; Jiang N; Chen LL; Liu F; Liu SQ; Ding CH; Wu SH; Wang KQ; Luo YY; Peng Y; Yan FZ; Zhang X; Qian H; Xie WF
J Hepatol; 2024 May; 80(5):778-791. PubMed ID: 38237865
[TBL] [Abstract][Full Text] [Related]
8. TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription.
Yu JM; Sun W; Wang ZH; Liang X; Hua F; Li K; Lv XX; Zhang XW; Liu YY; Yu JJ; Liu SS; Shang S; Wang F; Yang ZN; Zhao CX; Hou XY; Li PP; Huang B; Cui B; Hu ZW
Nat Commun; 2019 Dec; 10(1):5720. PubMed ID: 31844113
[TBL] [Abstract][Full Text] [Related]
9. Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival.
Xiao D; Yue M; Su H; Ren P; Jiang J; Li F; Hu Y; Du H; Liu H; Qing G
Mol Cell; 2016 Nov; 64(3):493-506. PubMed ID: 27773673
[TBL] [Abstract][Full Text] [Related]
10. TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway.
Hong B; Zhou J; Ma K; Zhang J; Xie H; Zhang K; Li L; Cai L; Zhang N; Zhang Z; Gong K
Int J Biol Sci; 2019; 15(3):587-597. PubMed ID: 30745845
[TBL] [Abstract][Full Text] [Related]
11. Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response.
Wennemers M; Bussink J; Scheijen B; Nagtegaal ID; van Laarhoven HW; Raleigh JA; Varia MA; Heuvel JJ; Rouschop KM; Sweep FC; Span PN
Breast Cancer Res; 2011 Aug; 13(4):R82. PubMed ID: 21864376
[TBL] [Abstract][Full Text] [Related]
12. TRIB3 confers glioma cell stemness via interacting with β-catenin.
Lu Y; Li L; Chen L; Gao Y; Chen X; Cao Y
Environ Toxicol; 2020 Jun; 35(6):697-706. PubMed ID: 31995275
[TBL] [Abstract][Full Text] [Related]
13. Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection.
Tran SC; Pham TM; Nguyen LN; Park EM; Lim YS; Hwang SB
J Virol; 2016 Aug; 90(16):7231-7247. PubMed ID: 27252525
[TBL] [Abstract][Full Text] [Related]
14. Tribbles-Related Protein Family Members as Regulators or Substrates of the Ubiquitin-Proteasome System in Cancer Development.
Sakai S; Miyajima C; Uchida C; Itoh Y; Hayashi H; Inoue Y
Curr Cancer Drug Targets; 2016; 16(2):147-56. PubMed ID: 26560117
[TBL] [Abstract][Full Text] [Related]
15. TRIB3 enhances cell viability during glucose deprivation in HEK293-derived cells by upregulating IGFBP2, a novel nutrient deficiency survival factor.
Örd T; Örd D; Adler P; Vilo J; Örd T
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2492-505. PubMed ID: 26094770
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity.
Paul I; Ahmed SF; Bhowmik A; Deb S; Ghosh MK
Oncogene; 2013 Mar; 32(10):1284-95. PubMed ID: 22543587
[TBL] [Abstract][Full Text] [Related]
17. Development and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosis.
Nguyen HV; Vandenberg CJ; Ng AP; Robati MR; Anstee NS; Rimes J; Hawkins ED; Cory S
Blood; 2020 Mar; 135(13):1019-1031. PubMed ID: 31978211
[TBL] [Abstract][Full Text] [Related]
18. FDA-approved drug screen identifies proteasome as a synthetic lethal target in MYC-driven neuroblastoma.
Wang J; Jiang J; Chen H; Wang L; Guo H; Yang L; Xiao D; Qing G; Liu H
Oncogene; 2019 Oct; 38(41):6737-6751. PubMed ID: 31406244
[TBL] [Abstract][Full Text] [Related]
19. SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein.
Geng C; Kaochar S; Li M; Rajapakshe K; Fiskus W; Dong J; Foley C; Dong B; Zhang L; Kwon OJ; Shah SS; Bolaki M; Xin L; Ittmann M; O'Malley BW; Coarfa C; Mitsiades N
Oncogene; 2017 Aug; 36(33):4767-4777. PubMed ID: 28414305
[TBL] [Abstract][Full Text] [Related]
20. Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation.
Xi Z; Yao M; Li Y; Xie C; Holst J; Liu T; Cai S; Lao Y; Tan H; Xu HX; Dong Q
Cell Death Dis; 2016 Jun; 7(6):e2252. PubMed ID: 27253416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
